‘Significant’ drop in MIS-C risk under Omicron: study Vaccination also looks to be confirmed as a factor in reducing the risk of complications in children after COVID-19 infection, according to new research.
Which diseases prompt the most spending in Australia? A new analysis published by the AIHW has ranked the spending per case of each disease in Australia for the first time.
HbA1c testing for type 2 diabetes in general practice SPONSORED: GPs have the central healthcare provider role from identifying those at risk to caring for diagnosed patients.
MBS point-of-care testing: What GPs need to know What does the new item mean for GPs and how does it align with the RACGP Standards?
Stigma limiting hepatitis C treatment Uptake has slowed despite Australians having access to highly effective treatment.
Inflammatory syndrome linked to SARS-CoV-2 can affect adults The CDC says the new adult syndrome closely resembles the previously identified paediatric one.
WHO develops preliminary case definition for inflammatory syndrome in children The COVID-19-associated syndrome seems to be its own unique entity.
Eliminating stigma in practice Stigma and discrimination can be significant barriers to healthcare for marginalised patients – but a new resource aims to help practitioners identify these barriers, and break through them.
GPs and better health outcomes for people in prison The RACGP’s Custodial health in Australia: Tips for providing healthcare to people in prison can help GPs in a unique area of healthcare.
New hepatitis C and diabetes medications available on the PBS Patients with hepatitis C and diabetes will be able to access more affordable treatments from this week, with important medications to be made available through the Pharmaceutical Benefits Scheme.